Literature DB >> 23177134

The basics of musculoskeletal magnetic resonance imaging: terminology, imaging sequences, image planes, and descriptions of basic pathologic change.

Matthew D Winter1.   

Abstract

The usefulness of magnetic resonance (MR) imaging in the diagnosis of equine lameness is unquestionable. As with most imaging modalities, advances in technology happen quickly, and the information that can be obtained can seem limitless. An understanding of MR sequences, expected signal intensity of normal tissues, and the role of multiplanar imaging is the foundation for interpreting MR images. The rapid development of new techniques and sequences and the potential for biochemical changes to be indirectly assessed using MR spectroscopy offer possibilities for the continued development of this modality and ensure its continued application in the diagnosis of equine lameness.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23177134     DOI: 10.1016/j.cveq.2012.09.001

Source DB:  PubMed          Journal:  Vet Clin North Am Equine Pract        ISSN: 0749-0739            Impact factor:   1.792


  2 in total

1.  MAGNETIC RESONANCE IMAGING SCORING OF AN EXPERIMENTAL MODEL OF POST-TRAUMATIC OSTEOARTHRITIS IN THE EQUINE CARPUS.

Authors:  Andrew D Smith; Alison J Morton; Matthew D Winter; Patrick T Colahan; Steve Ghivizzani; Murray P Brown; Jorge A Hernandez; David M Nickerson
Journal:  Vet Radiol Ultrasound       Date:  2016-05-19       Impact factor: 1.363

2.  Self-Complementary Adeno-Associated Virus-Mediated Interleukin-1 Receptor Antagonist Gene Delivery for the Treatment of Osteoarthritis: Test of Efficacy in an Equine Model.

Authors:  Rachael S Watson Levings; Andrew D Smith; Ted A Broome; Brett L Rice; Eric P Gibbs; David A Myara; E Viktoria Hyddmark; Elham Nasri; Ali Zarezadeh; Padraic P Levings; Yuan Lu; Margaret E White; E Anthony Dacanay; Gregory B Foremny; Christopher H Evans; Alison J Morton; Mathew Winter; Michael J Dark; David M Nickerson; Patrick T Colahan; Steven C Ghivizzani
Journal:  Hum Gene Ther Clin Dev       Date:  2018-06       Impact factor: 5.032

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.